Statement
8 May 2023
IFPMA statement for Multi-stakeholder Hearing on Tuberculosis
On 8 may, IFPMA read the following statement at the Multi-stakeholder Hearing on Tuberculosis (TB) in New York.
Read more
Toolkit
22 Mar 2023
Collaborating for Global Health Progress flyer
Discover how the innovative pharmaceutical industry works with partners to advance the SDGs
Read more
Statement
13 Sep 2022
R&D based biopharmaceutical industry statement in support of the Seventh Global Fund Replenishment
Ahead of the Global Fund Seventh Replenishment for 2024-2026, the innovative biopharmaceutical industry reaffirms its longstanding commitment to support the Global Fund mission to defeat HIV, TB, and malaria, and ensure a healthier, safer, more equitable future for all.
Read more